|Employees (est.) (Feb 2020)||21||(+5%)|
|Revenue (FY, 2018)||£396.6 K||(+38%)|
OMass Therapeutics total Funding
OMass Therapeutics latest funding size
Time since last funding
|a year ago|
OMass Therapeutics investors
|Oxford Sciences Innovation, Syncona Partners LLP|
Revenue (FY, 2018)
Gross profit (FY, 2018)
Gross profit margin (FY, 2018), %
Net income (FY, 2018)
EBIT (FY, 2018)
|GBP||FY, 2017||FY, 2018|
Cost of goods sold
Gross profit Margin, %
|GBP||FY, 2016||FY, 2017||FY, 2018|
OMass Therapeutics has 291 Twitter Followers. The number of followers has increased 8% month over month and increased 9.1% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was OMass Therapeutics founded?
OMass Therapeutics was founded in 2016.
Who are OMass Therapeutics key executives?
OMass Therapeutics's key executives are Rosamond Deegan, Ali Jazayeri and Jonathan Hopper.
How many employees does OMass Therapeutics have?
OMass Therapeutics has 21 employees.
What is OMass Therapeutics revenue?
Latest OMass Therapeutics annual revenue is £396.6 k.
What is OMass Therapeutics revenue per employee?
Latest OMass Therapeutics revenue per employee is £18.9 k.
Who are OMass Therapeutics competitors?
Competitors of OMass Therapeutics include Dermala, Frequency Therapeutics and Vividion Therapeutics.
Where is OMass Therapeutics headquarters?
OMass Therapeutics headquarters is located at Heatley Rd, The Oxford Science Park, Oxford.
Where are OMass Therapeutics offices?
OMass Therapeutics has an office in Oxford.
How many offices does OMass Therapeutics have?
OMass Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies